Dice Therapeutics Inc.
- Address
- 400 East Jamie Court Suite 300
Sponsor Overview
Specializations
Dermatology and Psoriasis
Dice Therapeutics Inc. concentrates its clinical research on plaque psoriasis, with studies centered on moderate-to-severe disease in adult participants. The company’s trial portfolio reflects a clear interest in skin inflammation and immune-mediated dermatologic disorders.
- Plaque psoriasis
- Moderate-to-severe psoriasis
- Adult dermatology
Its research activity includes evaluation of therapeutic candidates intended to address the clinical burden of persistent psoriatic skin disease.
Immunology and Inflammatory Disease
The sponsor’s work is closely aligned with immune-mediated inflammation, particularly conditions where abnormal immune signaling drives chronic skin symptoms. The funded trials indicate an ongoing focus on treatments for inflammatory pathways relevant to psoriatic disease.
- Immune-mediated inflammation
- Inflammatory skin disease
- Psoriatic disease
This area of interest connects therapeutic development with diseases that require targeted control of inflammatory activity.
Healthy Volunteer Research
Alongside disease-focused studies, Dice Therapeutics Inc. supports clinical research in healthy male participants to examine pharmacokinetics, metabolism, and excretion. These studies help define how candidate therapies behave in the body outside the disease setting.
- Healthy volunteers
- Pharmacokinetics
- Metabolism
The inclusion of healthy-participant research shows attention to foundational human data for orally administered compounds.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| A Multicenter, Randomized, Double-blind, Placebo- controlled, Parallel-group, Dose-ranging Study to Evaluate the Efficacy and Safety of DC-806 in Participants with Moderate to Severe Plaque Psoriasis |  Czechia Germany Hungary Poland Spain | Not Recruiting |
| Phase 1 Study on Excretion Balance, Pharmacokinetics, and Metabolism of [14C] DC 806 in Healthy Male Subjects |  The Netherlands | Not Recruiting |
| Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of LY4100511 in Adults with Moderate-to-Severe Plaque Psoriasis | Czechia Germany Hungary Poland | Not Recruiting |
Data & Insights
This sponsor works with 3 molecules, of which 3 are not being studied by other sponsors.
This sponsor has worked with 35 sites across their trial portfolio.
Therapeutic Focus
- 1.Skin and Connective Tissue Diseases3 trials247 other sponsors
Partnered Research Centres
35 centres- Address
- Baross Utca 20, 5000 Szolnok
- Address
- al. Wilanowska 333, 02-665 Warsaw
- Address
- Al. Wilanowska 333, 02-665 Warsaw
- Address
- Ul. Ul. Sliczna 13, 50-566 Wroclaw
- Address
- Aleja Jozefa Pilsudskiego 11, 20-011 Lublin
- Address
- Ul. Stoleczna 7/200, 15-879 Bialystok
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Dice Therapeutics Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.